Household & Personal Products
Compare Stocks
2 / 10Stock Comparison
GROV vs PRGO
Revenue, margins, valuation, and 5-year total return — side by side.
Drug Manufacturers - Specialty & Generic
GROV vs PRGO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Household & Personal Products | Drug Manufacturers - Specialty & Generic |
| Market Cap | $52M | $1.61B |
| Revenue (TTM) | $166M | $4.18B |
| Net Income (TTM) | $-9M | $-1.82B |
| Gross Margin | 54.1% | 34.2% |
| Operating Margin | -2.6% | -4.1% |
| Forward P/E | — | 5.6x |
| Total Debt | $20M | $3.97B |
| Cash & Equiv. | $8M | $532M |
GROV vs PRGO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 21 | May 26 | Return |
|---|---|---|---|
| Grove Collaborative… (GROV) | 100 | 2.5 | -97.5% |
| Perrigo Company plc (PRGO) | 100 | 25.4 | -74.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GROV vs PRGO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GROV carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- beta 1.14
- Lower volatility, beta 1.14, current ratio 1.25x
- Beta 1.14, current ratio 1.25x
PRGO is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth -2.8%, EPS growth -7.2%, 3Y rev CAGR -1.5%
- -77.7% 10Y total return vs GROV's -97.5%
- -2.8% revenue growth vs GROV's -14.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -2.8% revenue growth vs GROV's -14.6% | |
| Quality / Margins | -5.5% margin vs PRGO's -43.5% | |
| Stability / Safety | Beta 1.14 vs PRGO's 1.18 | |
| Dividends | 9.8% yield; 10-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +6.0% vs PRGO's -51.2% | |
| Efficiency (ROA) | -16.9% ROA vs PRGO's -19.8%, ROIC -31.7% vs 3.7% |
GROV vs PRGO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
GROV vs PRGO — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
GROV leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PRGO is the larger business by revenue, generating $4.2B annually — 25.1x GROV's $166M. GROV is the more profitable business, keeping -5.5% of every revenue dollar as net income compared to PRGO's -43.5%. On growth, PRGO holds the edge at -7.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $166M | $4.2B |
| EBITDAEarnings before interest/tax | -$3M | $58M |
| Net IncomeAfter-tax profit | -$9M | -$1.8B |
| Free Cash FlowCash after capex | -$2M | $108M |
| Gross MarginGross profit ÷ Revenue | +54.1% | +34.2% |
| Operating MarginEBIT ÷ Revenue | -2.6% | -4.1% |
| Net MarginNet income ÷ Revenue | -5.5% | -43.5% |
| FCF MarginFCF ÷ Revenue | -1.0% | +2.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -16.8% | -7.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +70.0% | -56.4% |
Valuation Metrics
GROV leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $52M | $1.6B |
| Enterprise ValueMkt cap + debt − cash | $64M | $5.1B |
| Trailing P/EPrice ÷ TTM EPS | -3.62x | -1.14x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 5.56x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 7.42x |
| Price / SalesMarket cap ÷ Revenue | 0.30x | 0.38x |
| Price / BookPrice ÷ Book value/share | 6.18x | 0.55x |
| Price / FCFMarket cap ÷ FCF | — | 11.12x |
Profitability & Efficiency
PRGO leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
PRGO delivers a -50.7% return on equity — every $100 of shareholder capital generates $-51 in annual profit, vs $-106 for GROV. PRGO carries lower financial leverage with a 1.35x debt-to-equity ratio, signaling a more conservative balance sheet compared to GROV's 2.63x. On the Piotroski fundamental quality scale (0–9), PRGO scores 4/9 vs GROV's 3/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -106.3% | -50.7% |
| ROA (TTM)Return on assets | -16.9% | -19.8% |
| ROICReturn on invested capital | -31.7% | +3.7% |
| ROCEReturn on capital employed | -25.6% | +4.3% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 |
| Debt / EquityFinancial leverage | 2.63x | 1.35x |
| Net DebtTotal debt minus cash | $12M | $3.4B |
| Cash & Equiv.Liquid assets | $8M | $532M |
| Total DebtShort + long-term debt | $20M | $4.0B |
| Interest CoverageEBIT ÷ Interest expense | -3.79x | -7.20x |
Total Returns (Dividends Reinvested)
GROV leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PRGO five years ago would be worth $3,986 today (with dividends reinvested), compared to $250 for GROV. Over the past 12 months, GROV leads with a +6.0% total return vs PRGO's -51.2%. The 3-year compound annual growth rate (CAGR) favors GROV at -20.0% vs PRGO's -25.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +9.8% | -13.5% |
| 1-Year ReturnPast 12 months | +6.0% | -51.2% |
| 3-Year ReturnCumulative with dividends | -48.9% | -58.1% |
| 5-Year ReturnCumulative with dividends | -97.5% | -60.1% |
| 10-Year ReturnCumulative with dividends | -97.5% | -77.7% |
| CAGR (3Y)Annualised 3-year return | -20.0% | -25.2% |
Risk & Volatility
GROV leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
GROV is the less volatile stock with a 1.14 beta — it tends to amplify market swings less than PRGO's 1.18 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GROV currently trades 66.8% from its 52-week high vs PRGO's 41.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.14x | 1.18x |
| 52-Week HighHighest price in past year | $1.84 | $28.44 |
| 52-Week LowLowest price in past year | $1.03 | $9.23 |
| % of 52W HighCurrent price vs 52-week peak | +66.8% | +41.2% |
| RSI (14)Momentum oscillator 0–100 | 49.1 | 60.9 |
| Avg Volume (50D)Average daily shares traded | 81K | 3.4M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
PRGO is the only dividend payer here at 9.81% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold |
| Price TargetConsensus 12-month target | — | $20.00 |
| # AnalystsCovering analysts | — | 36 |
| Dividend YieldAnnual dividend ÷ price | — | +9.8% |
| Dividend StreakConsecutive years of raises | — | 10 |
| Dividend / ShareAnnual DPS | — | $1.15 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
GROV leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). PRGO leads in 1 (Profitability & Efficiency).
GROV vs PRGO: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is GROV or PRGO a better buy right now?
For growth investors, Perrigo Company plc (PRGO) is the stronger pick with -2.
8% revenue growth year-over-year, versus -14. 6% for Grove Collaborative Holdings, Inc. (GROV). Analysts rate Perrigo Company plc (PRGO) a "Hold" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — GROV or PRGO?
Over the past 5 years, Perrigo Company plc (PRGO) delivered a total return of -60.
1%, compared to -97. 5% for Grove Collaborative Holdings, Inc. (GROV). Over 10 years, the gap is even starker: PRGO returned -77. 7% versus GROV's -97. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — GROV or PRGO?
By beta (market sensitivity over 5 years), Grove Collaborative Holdings, Inc.
(GROV) is the lower-risk stock at 1. 14β versus Perrigo Company plc's 1. 18β — meaning PRGO is approximately 3% more volatile than GROV relative to the S&P 500. On balance sheet safety, Perrigo Company plc (PRGO) carries a lower debt/equity ratio of 135% versus 3% for Grove Collaborative Holdings, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — GROV or PRGO?
By revenue growth (latest reported year), Perrigo Company plc (PRGO) is pulling ahead at -2.
8% versus -14. 6% for Grove Collaborative Holdings, Inc. (GROV). On earnings-per-share growth, the picture is similar: Grove Collaborative Holdings, Inc. grew EPS 55. 3% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, PRGO leads at -1. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — GROV or PRGO?
Grove Collaborative Holdings, Inc.
(GROV) is the more profitable company, earning -6. 7% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps -6. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PRGO leads at 8. 1% versus -4. 7% for GROV. At the gross margin level — before operating expenses — GROV leads at 53. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — GROV or PRGO?
In this comparison, PRGO (9.
8% yield) pays a dividend. GROV does not pay a meaningful dividend and should not be held primarily for income.
07Is GROV or PRGO better for a retirement portfolio?
For long-horizon retirement investors, Perrigo Company plc (PRGO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
18), 9. 8% yield). Both have compounded well over 10 years (PRGO: -77. 7%, GROV: -97. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between GROV and PRGO?
These companies operate in different sectors (GROV (Consumer Defensive) and PRGO (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: GROV is a small-cap quality compounder stock; PRGO is a small-cap income-oriented stock. PRGO pays a dividend while GROV does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.